Network Analysis of Down Syndrome and SARS-CoV-2 Identifies Risk and Protective Factors for COVID-19

Overview

Journal Sci Rep

Specialty Science

Date 2021 Jan 22

PMID 33479353

Citations 30

Authors

Ilario De Toma

Mara Dierssen

Affiliations

Soon will be listed here.

Abstract

SARS-CoV-2 infection has spread uncontrollably worldwide while it remains unknown how vulnerable populations, such as Down syndrome (DS) individuals are affected by the COVID-19 pandemic. Individuals with DS have more risk of infections with respiratory complications and present signs of auto-inflammation. They also present with multiple comorbidities that are associated with poorer COVID-19 prognosis in the general population. All this might place DS individuals at higher risk of SARS-CoV-2 infection or poorer clinical outcomes. In order to get insight into the interplay between DS genes and SARS-cov2 infection and pathogenesis we identified the genes associated with the molecular pathways involved in COVID-19 and the host proteins interacting with viral proteins from SARS-CoV-2. We then analyzed the overlaps of these genes with HSA21 genes, HSA21 interactors and other genes consistently differentially expressed in DS (using public transcriptomic datasets) and created a DS-SARS-CoV-2 network. We detected COVID-19 protective and risk factors among HSA21 genes and interactors and/or DS deregulated genes that might affect the susceptibility of individuals with DS both at the infection stage and in the progression to acute respiratory distress syndrome. Our analysis suggests that at the infection stage DS individuals might be more susceptible to infection due to triplication of TMPRSS2, that primes the viral S protein for entry in the host cells. However, as the anti-viral interferon I signaling is also upregulated in DS, this might increase the initial anti-viral response, inhibiting viral genome release, viral replication and viral assembly. In the second pro-inflammatory immunopathogenic phase of the infection, the prognosis for DS patients might worsen due to upregulation of inflammatory genes that might favor the typical cytokine storm of COVID-19. We also detected strong downregulation of the NLRP3 gene, critical for maintenance of homeostasis against pathogenic infections, possibly leading to bacterial infection complications.

Citing Articles

Integrated analysis of immunometabolic interactions in Down syndrome.

Gillenwater L, Galbraith M, Rachubinski A, Eduthan N, Sullivan K, Espinosa J Sci Adv. 2024; 10(50):eadq3073.

PMID: 39671500 PMC: 11641111. DOI: 10.1126/sciadv.adq3073.

Down syndrome frontal cortex layer III and layer V pyramidal neurons exhibit lamina specific degeneration in aged individuals.

Alldred M, Ibrahim K, Pidikiti H, Chiosis G, Mufson E, Stutzmann G Acta Neuropathol Commun. 2024; 12(1):182.

PMID: 39605035 PMC: 11603868. DOI: 10.1186/s40478-024-01891-z.

The Impact of the COVID-19 Pandemic on Individuals with Down Syndrome: A Croatian Survey.

Barisic A, Ergovic Ravancic M, Majstorovic D, Vranekovic J Balkan J Med Genet. 2024; 27(1):51-58.

PMID: 39263648 PMC: 11383832. DOI: 10.2478/bjmg-2024-0007.

Analysis of microisolated frontal cortex excitatory layer III and V pyramidal neurons reveals a neurodegenerative phenotype in individuals with Down syndrome.

Alldred M, Pidikiti H, Ibrahim K, Lee S, Heguy A, Hoffman G Acta Neuropathol. 2024; 148(1):16.

PMID: 39105932 PMC: 11578391. DOI: 10.1007/s00401-024-02768-0.

Choroid plexus defects in Down syndrome brain organoids enhance neurotropism of SARS-CoV-2.

Shaker M, Slonchak A, Al-Mhanawi B, Morrison S, Sng J, Cooper-White J Sci Adv. 2024; 10(23):eadj4735.

PMID: 38838150 PMC: 11152128. DOI: 10.1126/sciadv.adj4735.

References

Kusters M, Manders N, de Jong B, van Hout R, Rijkers G, de Vries E . Functionality of the pneumococcal antibody response in Down syndrome subjects. Vaccine. 2013; 31(52):6261-5. DOI: 10.1016/j.vaccine.2013.09.070. View

Drappier M, Michiels T . Inhibition of the OAS/RNase L pathway by viruses. Curr Opin Virol. 2015; 15:19-26. PMC: 7185432. DOI: 10.1016/j.coviro.2015.07.002. View

Nakamura K, Hirohata S, Murakami T, Miyoshi T, Demircan K, Oohashi T . Dynamic induction of ADAMTS1 gene in the early phase of acute myocardial infarction. J Biochem. 2004; 136(4):439-46. DOI: 10.1093/jb/mvh138. View

Mowery C, Reyes J, Cabal-Hierro L, Higby K, Karlin K, Wang J . Trisomy of a Down Syndrome Critical Region Globally Amplifies Transcription via HMGN1 Overexpression. Cell Rep. 2018; 25(7):1898-1911.e5. PMC: 6321629. DOI: 10.1016/j.celrep.2018.10.061. View

Hibaoui Y, Grad I, Letourneau A, Sailani M, Dahoun S, Santoni F . Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21. EMBO Mol Med. 2013; 6(2):259-77. PMC: 3927959. DOI: 10.1002/emmm.201302848. View

Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A . BioMart and Bioconductor: a powerful link between biological databases and microarray data analysis. Bioinformatics. 2005; 21(16):3439-40. DOI: 10.1093/bioinformatics/bti525. View

de Hingh Y, van der Vossen P, Gemen E, Mulder A, Hop W, Brus F . Intrinsic abnormalities of lymphocyte counts in children with down syndrome. J Pediatr. 2005; 147(6):744-7. DOI: 10.1016/j.jpeds.2005.07.022. View

Pennings J, Rodenburg W, Imholz S, Koster M, van Oostrom C, Breit T . Gene expression profiling in a mouse model identifies fetal liver- and placenta-derived potential biomarkers for Down Syndrome screening. PLoS One. 2011; 6(4):e18866. PMC: 3077415. DOI: 10.1371/journal.pone.0018866. View

Huang I, Bailey C, Weyer J, Radoshitzky S, Becker M, Chiang J . Distinct patterns of IFITM-mediated restriction of filoviruses, SARS coronavirus, and influenza A virus. PLoS Pathog. 2011; 7(1):e1001258. PMC: 3017121. DOI: 10.1371/journal.ppat.1001258. View

10.

Letourneau A, Santoni F, Bonilla X, Sailani M, Gonzalez D, Kind J . Domains of genome-wide gene expression dysregulation in Down's syndrome. Nature. 2014; 508(7496):345-50. DOI: 10.1038/nature13200. View

11.

Granese B, Scala I, Spatuzza C, Valentino A, Coletta M, Vacca R . Validation of microarray data in human lymphoblasts shows a role of the ubiquitin-proteasome system and NF-kB in the pathogenesis of Down syndrome. BMC Med Genomics. 2013; 6:24. PMC: 3717290. DOI: 10.1186/1755-8794-6-24. View

12.

Durinck S, Spellman P, Birney E, Huber W . Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt. Nat Protoc. 2009; 4(8):1184-91. PMC: 3159387. DOI: 10.1038/nprot.2009.97. View

13.

De Toma I, Manubens-Gil L, Ossowski S, Dierssen M . Where Environment Meets Cognition: A Focus on Two Developmental Intellectual Disability Disorders. Neural Plast. 2016; 2016:4235898. PMC: 4980517. DOI: 10.1155/2016/4235898. View

14.

Bianco K, Gormley M, Farrell J, Zhou Y, Oliverio O, Tilden H . Placental transcriptomes in the common aneuploidies reveal critical regions on the trisomic chromosomes and genome-wide effects. Prenat Diagn. 2016; 36(9):812-22. PMC: 5104283. DOI: 10.1002/pd.4862. View

15.

Bloemers B, Marceline van Furth A, Weijerman M, Gemke R, Broers C, van den Ende K . Down syndrome: a novel risk factor for respiratory syncytial virus bronchiolitis--a prospective birth-cohort study. Pediatrics. 2007; 120(4):e1076-81. DOI: 10.1542/peds.2007-0788. View

16.

Startin C, DSouza H, Ball G, Hamburg S, Hithersay R, Hughes K . Health comorbidities and cognitive abilities across the lifespan in Down syndrome. J Neurodev Disord. 2020; 12(1):4. PMC: 6979347. DOI: 10.1186/s11689-019-9306-9. View

17.

de la Torre R, de Sola S, Hernandez G, Farre M, Pujol J, Rodriguez J . Safety and efficacy of cognitive training plus epigallocatechin-3-gallate in young adults with Down's syndrome (TESDAD): a double-blind, randomised, placebo-controlled, phase 2 trial. Lancet Neurol. 2016; 15(8):801-810. DOI: 10.1016/S1474-4422(16)30034-5. View

18.

Wilson M, Barbosa-Morais N, Schmidt D, Conboy C, Vanes L, Tybulewicz V . Species-specific transcription in mice carrying human chromosome 21. Science. 2008; 322(5900):434-8. PMC: 3717767. DOI: 10.1126/science.1160930. View

19.

Hertzberg L, Vendramini E, Ganmore I, Cazzaniga G, Schmitz M, Chalker J . Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group. Blood. 2009; 115(5):1006-17. DOI: 10.1182/blood-2009-08-235408. View

20.

De Cegli R, Romito A, Iacobacci S, Mao L, Lauria M, Fedele A . A mouse embryonic stem cell bank for inducible overexpression of human chromosome 21 genes. Genome Biol. 2010; 11(6):R64. PMC: 2911112. DOI: 10.1186/gb-2010-11-6-r64. View